Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +279.8% | +87.8% | 2 / 3 | +12.9% | +6.64 pp | +8.03 pp | +7.8% | 0.26 | 18.73 | 42,1 | +12,9% | 4,8 | +279,8% | 18.73 | 11.85 | +58,0% |
| Pts | 12 | 12 | 8 | 4 | 12 | 12 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 15.500 (close price on 2026-10-16)EPS (TTM): 827,6
Financial charts
1.Revenue & growth
VND bn42,1Q2/26
1.Revenue & growth
VND bn42,1Q2/26
2.Profit & growth
VND bn5,77Q2/26
3.Profit mix (Penman)
VND bn12,9Q2/26
4.Margins & cost structure
%24.6%Q2/26
5.Returns & cash cycle
% · days7.4%Q2/26
6.Earnings quality & cash
VND bn33,1Q2/26
7.Asset structure
VND bn197Q2/26
8.Funding & debt health
VND bn · times197Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %17,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %461Q2/26
Adjusted EPS growth, latest quarter
356%
Average adjusted EPS growth, 3 quarters
356%
averaged over 1 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26